These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 20308784)

  • 21. Altered beta-secretase enzyme kinetics and levels of both BACE1 and BACE2 in the Alzheimer's disease brain.
    Stockley JH; Ravid R; O'Neill C
    FEBS Lett; 2006 Dec; 580(28-29):6550-60. PubMed ID: 17113083
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pro-inflammatory cytokines IL-1β and TNF-α are not associated with plasma homocysteine concentration in Alzheimer's disease.
    Veryard L; Jones E; Weaving G; Smith E; Cheek L; Wickramasinghe A; Tabet N
    Curr Alzheimer Res; 2013 Feb; 10(2):174-9. PubMed ID: 23463936
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oxidative imbalance in patients with mild cognitive impairment and Alzheimer's disease.
    Guidi I; Galimberti D; Lonati S; Novembrino C; Bamonti F; Tiriticco M; Fenoglio C; Venturelli E; Baron P; Bresolin N; Scarpini E
    Neurobiol Aging; 2006 Feb; 27(2):262-9. PubMed ID: 16399211
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased tissue factor pathway inhibitor and homocysteine in Alzheimer's disease.
    Piazza F; Galimberti G; Conti E; Isella V; Perlangeli MV; Speranza T; Borroni B; Pogliani EM; Padovani A; Ferrarese C
    Neurobiol Aging; 2012 Feb; 33(2):226-33. PubMed ID: 20359777
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metabolism and neurotoxicity of homocysteine thiolactone in mice: protective role of bleomycin hydrolase.
    Borowczyk K; Tisończyk J; Jakubowski H
    Amino Acids; 2012 Sep; 43(3):1339-48. PubMed ID: 22227865
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protective mechanisms against homocysteine toxicity: the role of bleomycin hydrolase.
    Zimny J; Sikora M; Guranowski A; Jakubowski H
    J Biol Chem; 2006 Aug; 281(32):22485-92. PubMed ID: 16769724
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plasminogen and plasmin in Alzheimer's disease.
    Barker R; Love S; Kehoe PG
    Brain Res; 2010 Oct; 1355():7-15. PubMed ID: 20709033
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hyperhomocysteinemia and bleomycin hydrolase modulate the expression of mouse brain proteins involved in neurodegeneration.
    Suszyńska-Zajczyk J; Luczak M; Marczak L; Jakubowski H
    J Alzheimers Dis; 2014; 40(3):713-26. PubMed ID: 24496069
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic evidence for oxidative stress in Alzheimer's disease.
    Raina AK; Takeda A; Nunomura A; Perry G; Smith MA
    Neuroreport; 1999 Apr; 10(6):1355-7. PubMed ID: 10363952
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protein kinase activity profiling of postmortem human brain tissue.
    Hoozemans JJ; Hilhorst R; Ruijtenbeek R; Rozemuller AJ; van der Vies SM
    Neurodegener Dis; 2012; 10(1-4):46-8. PubMed ID: 22343098
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetic determinants of homocysteine thiolactonase activity in humans: implications for atherosclerosis.
    Jakubowski H; Ambrosius WT; Pratt JH
    FEBS Lett; 2001 Feb; 491(1-2):35-9. PubMed ID: 11226414
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phospholipase C-η activity may contribute to Alzheimer's disease-associated calciumopathy.
    Popovics P; Stewart AJ
    J Alzheimers Dis; 2012; 30(4):737-44. PubMed ID: 22475800
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dissecting the Role of 5-Lipoxygenase in the Homocysteine-Induced Alzheimer's Disease Pathology.
    Di Meco A; Li JG; Praticò D
    J Alzheimers Dis; 2018; 62(3):1337-1344. PubMed ID: 29254095
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regional and cellular distribution of bleomycin hydrolase mRNA in human brain: comparison between Alzheimer's diseased and control brains.
    Malherbe P; Faull RL; Richards JG
    Neurosci Lett; 2000 Mar; 281(1):37-40. PubMed ID: 10686410
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Changes of renin-angiotensin system-related aminopeptidases in early stage Alzheimer's disease.
    Gard PR; Fidalgo S; Lotter I; Richardson C; Farina N; Rusted J; Tabet N
    Exp Gerontol; 2017 Mar; 89():1-7. PubMed ID: 28069385
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ribonuclease activities and distribution in Alzheimer's and control brains.
    Maschhoff K; White CL; Jennings LW; Morrison-Bogorad MR
    J Neurochem; 1989 Apr; 52(4):1071-8. PubMed ID: 2926389
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A quantitative method for the assessment of homocysteine thiolactonase enzyme activity.
    Obeid NJ; Hadwan MH
    Anal Biochem; 2021 Oct; 631():114365. PubMed ID: 34506754
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pro-inflammatory cytokines IL-1β and TNF-α are not associated with blood homocysteine concentration in Alzheimer's disease.
    Veryard L; Jones E; Weaving G; Smith E; Cheek L; Wickramasinghe A; Tabet N
    Curr Alzheimer Res; 2012 Oct; ():. PubMed ID: 23036021
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reductions in brain phosphatidylinositol kinase activities in Alzheimer's disease.
    Zubenko GS; Stiffler JS; Hughes HB; Martinez AJ
    Biol Psychiatry; 1999 Mar; 45(6):731-6. PubMed ID: 10188002
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quantitative cytochemistry of cytochrome oxidase and cellular morphometry of the human inferior colliculus in control and Alzheimer's patients.
    Gonzalez-Lima F; Valla J; Matos-Collazo S
    Brain Res; 1997 Mar; 752(1-2):117-26. PubMed ID: 9106447
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.